| CTRI Number |
CTRI/2023/07/055416 [Registered on: 20/07/2023] Trial Registered Prospectively |
| Last Modified On: |
19/07/2023 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda Diagnostic Preventive |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Triphaladi Kwatha will be given to patients of Diabetes mellitus. |
|
Scientific Title of Study
|
Clinical Evaluation of Triphaladi Kwatha in Madhumeha (Type 2 Diabetes Mellitus)
|
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Arun Verma |
| Designation |
PG Scholar |
| Affiliation |
UTTARAKHAND AYURVEDA UNIVERSITY GURUKUL CAMPUS HARIDWAR |
| Address |
Department of Kayachikitsa OPD 05 Uttarakhand Ayurveda University Gurukul Campus Haridwar
Hardwar UTTARANCHAL 249404 India |
| Phone |
9219074978 |
| Fax |
|
| Email |
arunverma222111@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Punita Pandey |
| Designation |
Professor |
| Affiliation |
UTTARAKHAND AYURVEDA UNIVERSITY GURUKUL CAMPUS HARIDWAR |
| Address |
OPD 05 Department of Kayachikitsa Uttarakhand Ayurveda University Gurukul Campus Haridwar OPD 05 Department of Kayachikitsa Uttarakhand Ayurveda University Gurukul Campus Haridwar Hardwar UTTARANCHAL 249404 India |
| Phone |
9319394485 |
| Fax |
|
| Email |
pandey.punita62@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
ARUN VERMA |
| Designation |
PG SCHOLAR |
| Affiliation |
UTTARAKHAND AYURVEDA UNIVERSITY GURUKUL CAMPUS HARIDWAR |
| Address |
Department of Kayachikitsa OPD 05 Uttarakhand Ayurveda University Gurukul Campus Haridwar
Hardwar UTTARANCHAL 249404 India |
| Phone |
9219074978 |
| Fax |
|
| Email |
arunverma222111@gmail.com |
|
|
Source of Monetary or Material Support
|
| Arun Verma OPD 05 Department of Kayachikitsa Uttarakhand Ayurveda University Gurukul Campus Haridwar |
|
|
Primary Sponsor
|
| Name |
Arun Verma |
| Address |
OPD 05 PG DEPARTMENT OF KAYACHIKITSA UTTARAKHAND AYURVEDA UNIVERSITY GURUKUL CAMPUS HARIDWAR |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Arun Verma |
Uttarakhand Ayurveda University Gurukul Campus Haridwar |
OPD 05 Department of Kayachikitsa Uttarakhand Ayurveda University Gurukul Campus Haridwar Hardwar UTTARANCHAL |
9219074978
arunverma222111@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| IEC UAU Gurukul Campus Haridwar |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: MADHUMEHAH/KSHAUDRAMEHAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Triphaladi kwatha, Reference: Charaka Samhita, Sutrasthana,23/10,11, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Samudga, Duration: 90 Days, anupAna/sahapAna: No, Additional Information: NOT ANY |
|
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
Patient willing to sign the consent form
Patients between the age group of 20-70 years
Fasting blood glucose level
(FBS)≥126mg/dl≤350mg/dl
Post Prandial blood sugar level
(PPBS)≥200mg/dl≤450mg/dl
HbA1c≥6.5%≤13%. |
|
| ExclusionCriteria |
| Details |
Patients of type 1 Diabetes Mellitus
Age below 20years and above 70 years
Blood sugar- fasting blood sugar level>350mg/dl
Post Prandial blood sugar level>450mg/dl
Patients having complications
Patients suffering from any serious medical or
surgical illness |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Case Record Numbers |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
1) PRABHUTA MUTRATA (Excessive Urination)
2) AVILMUTRATA (Turbidity in Urine)
3) KSHUDHA-ADHIKA (Excessive Hunger)
4) PIPSAS ADHIKA (Excessive Thirst)
5) KARA PADA DAHA (Burning Sensation of Hands & Feet)
6) DAURBALYA (Weakness) |
Assessment will be done every 15th day and the patients
will be followed up on 7th day and 14th day after completion of trial |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
• BLOOD SUGAR- FASTING
• BLOOD SUGAR-POST PRANDIAL
• HbA1c
• URINE SUGAR
• BODY WEIGHT
• BMI |
At 1st & 90th day. |
|
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
29/07/2023 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="9" Days="10" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This study is open label clinical trial to determine the efficacy of Triphaladi kwatha in Madhumeha ( Diabetes mellitus) for age group between 20-70 years, daily for 90 days. The study will be conducted at UAU gurukul campus, Haridwar on 40 patients. The assessment will be done on the basis of subjective and objective parameters. The study will be conducted at OPD/IPD level of P.G department of kayachikitsa. The assessment will be done at the interval of 15 days of the clinical trial and the results obtained will be tabulated and statically analyzed using appropriate tests. |